Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lighter You vs No BS RX

Lighter You
Graded #71

Lower grade

vs+8.5
No BS RX
Graded #26

Higher grade

The verdict

No BS RX takes it — 82.8/100 to 74.3/100.

No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Twenty-four prices on one public page, four dispensing pharmacies named with street addresses, and a no-intro-rate promise the arithmetic actually supports.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNo BS RX +23
69
92
Dose & formulationNo BS RX +15
75
90
Clinical oversightNo BS RX +2
70
72
Labs & monitoringLighter You +3
71
68
FulfillmentNo BS RX +6
88
94
Contract termsLighter You +11
85
74
Lighter You · left barNo BS RX · right bar

The numbers

MetricLighter YouNo BS RX
WeighScore74.3/10082.8/100
GradeCB−
Scorecard rank#71#26
Semaglutide$169 per 4 weeks (store and intake price; thirteen charges a year)$179/mo month-to-month (a separate low-dose program is $140)
Tirzepatide$339 per 4 weeks (store and intake price; the marketing site advertises $169)$249/mo month-to-month (a separate low-dose program is $140)
CoverageAll 50 states plus Washington, D.C. (claimed; the footer says otherwise)Not publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Lighter You

Graded #71 · C

Strengths

  • The store and the intake agree with each other, so a reader who starts at the store sees the figure that will be charged
  • Names four dispensing pharmacies with addresses and phone numbers
  • Runs oral, microdose and injectable GLP-1 lines plus a separate peptide sub-brand, so the menu is unusually wide for the price band
  • Unlimited video visits and dietitian check-ins are described as included in every plan
  • A full refund is offered if a clinician declines the prescription

Where it loses points

  • Tirzepatide is advertised at $169 a month on the marketing site and sold at $339 per four weeks in the store and the intake
  • The marketing site says “/mo” and the store bills per four weeks, which is thirteen charges a year rather than twelve
  • GLP-1 tablets are advertised at $249 and sold at $279 per four weeks; microdosing is advertised at $96 and sold at $179
  • The peptide sub-brand prices the same products differently again — NAD+ at $199 against $229, sermorelin at $175 against $229
  • The Terms claim all 50 states plus Washington, D.C. and the footer on the same site says not available in all 50 states
  • No clinician, medical group or NPI is named, and no compounding class appears anywhere on the domain
  • A dietitian visit is promised on the homepage with an asterisk that resolves to no footnote, and neither the Terms nor the refund policy promises one
No BS RX

Graded #26 · B−

Strengths

  • Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
  • "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
  • Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
  • Six programs across four terms are published with no intake and no account
  • A sleep program is priced on the same page, including a diagnostic ring study at $33/mo

Where it loses points

  • The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
  • The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
  • The Terms name four pharmacies and no operating company
  • State availability is not published, and there is no FDA-approved brand lane

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard